NACDS Offers Key Planning Recommendations for the Commercial Transition of COVID-19 Vaccinations to Help Foster Seamless, Ongoing Access for the American Public Letter to Biden Administration also urges the importance of advanced planning to support seamless public access to commercial COVID-19 testing and therapeutics
On Thursday, NACDS submitted a letter to the Biden Administration detailing five key recommendations to support a seamless transition of COVID-19 vaccinations from government-purchased product to commercially available supply — while maintaining patients’ critical access to care.